Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Expert Review of Clinical Pharmacology
|
November 16, 2020
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
Kyle A Williams, Youkyung S Roh, Isabelle Brown, et al.
The Journal of Clinical and Aesthetic Dermatology
|
August 9, 2022
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris
James Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, et al.
American Journal of Clinical Dermatology
|
October 27, 2021
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
JAAD International
|
January 10, 2022
Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
Dermatology and Therapy
|
July 29, 2022
Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
JAAD International
|
August 19, 2021
Impact of facial and truncal acne on quality of life: A multi-country population-based survey
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
Acta Dermato-Venereologica
|
April 23, 2025
Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl Aminolevulinate
Rolf-Markus Szeimies, Matthias Brückner, Matthias Hoffmann, et al.
The British Journal of Dermatology
|
November 7, 2024
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight
Wolfgang G Philipp-Dormston, Matthias Brückner, Matthias Hoffmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 2, 2019
Randomized, double-blind, placebo-controlled study of F17464, a preferential D<sub>3</sub> antagonist, in the treatment of acute exacerbation of schizophrenia
Istvan Bitter, Jeffrey A Lieberman, Florence Gaudoux, et al.
Journal of the American Academy of Dermatology
|
May 31, 2021
Health-related quality of life and economic burden of prurigo nodularis
Katherine A Whang, Thomas K Le, Raveena Khanna, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Expert Review of Clinical Pharmacology
|
November 16, 2020
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
Kyle A Williams, Youkyung S Roh, Isabelle Brown, et al.
The Journal of Clinical and Aesthetic Dermatology
|
August 9, 2022
A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris
James Q Del Rosso, Sandra Marchese Johnson, Todd Schlesinger, et al.
American Journal of Clinical Dermatology
|
October 27, 2021
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
JAAD International
|
January 10, 2022
Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
Dermatology and Therapy
|
July 29, 2022
Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
JAAD International
|
August 19, 2021
Impact of facial and truncal acne on quality of life: A multi-country population-based survey
Jerry Tan, Stefan Beissert, Fran Cook-Bolden, et al.
Acta Dermato-Venereologica
|
April 23, 2025
Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl Aminolevulinate
Rolf-Markus Szeimies, Matthias Brückner, Matthias Hoffmann, et al.
The British Journal of Dermatology
|
November 7, 2024
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLight
Wolfgang G Philipp-Dormston, Matthias Brückner, Matthias Hoffmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 2, 2019
Randomized, double-blind, placebo-controlled study of F17464, a preferential D<sub>3</sub> antagonist, in the treatment of acute exacerbation of schizophrenia
Istvan Bitter, Jeffrey A Lieberman, Florence Gaudoux, et al.
Journal of the American Academy of Dermatology
|
May 31, 2021
Health-related quality of life and economic burden of prurigo nodularis
Katherine A Whang, Thomas K Le, Raveena Khanna, et al.
Page
of 6